Replies to post #376 on Ophthotech Corp. (OPHT)

[naturalborninvestor]

Still $5 cash per share, Zimura and a clean Nasdaq shell. I'd prefer a private biotech reverse merger as soon as possible, but looks like management is waiting for Zimura results first before repositioning.